IRIS
PELLEGRITI, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.700
AS - Asia 1.665
EU - Europa 1.458
AF - Africa 298
SA - Sud America 245
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.371
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.599
CN - Cina 717
SG - Singapore 657
IT - Italia 579
IE - Irlanda 254
CI - Costa d'Avorio 248
BR - Brasile 219
UA - Ucraina 205
KR - Corea 142
DE - Germania 134
CA - Canada 84
RU - Federazione Russa 69
SE - Svezia 43
GB - Regno Unito 39
IN - India 37
VN - Vietnam 34
SN - Senegal 30
FI - Finlandia 26
NL - Olanda 21
FR - Francia 16
CZ - Repubblica Ceca 14
PL - Polonia 12
MX - Messico 11
AR - Argentina 9
BD - Bangladesh 9
CH - Svizzera 9
HK - Hong Kong 9
AT - Austria 8
ES - Italia 8
TR - Turchia 8
UZ - Uzbekistan 8
ID - Indonesia 7
JP - Giappone 6
AZ - Azerbaigian 5
BE - Belgio 5
CO - Colombia 5
NG - Nigeria 5
CL - Cile 4
EC - Ecuador 4
IQ - Iraq 4
LB - Libano 4
PK - Pakistan 4
TN - Tunisia 4
ZA - Sudafrica 4
BG - Bulgaria 3
RO - Romania 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
EU - Europa 2
GR - Grecia 2
KG - Kirghizistan 2
MA - Marocco 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BJ - Benin 1
BZ - Belize 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
IM - Isola di Man 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
ML - Mali 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 7.371
Salva come PNG Salva come JPEG
Città #
Dallas 741
Santa Clara 588
Singapore 457
Chandler 406
Hefei 271
Dublin 254
Abidjan 248
Chicago 220
Jacksonville 192
Houston 179
Seoul 142
Boardman 139
Catania 93
Ashburn 91
Los Angeles 91
Civitanova Marche 89
Beijing 81
Grafing 76
Cambridge 69
Andover 67
Lawrence 67
Nanjing 67
Toronto 56
Wilmington 40
Dakar 30
San Mateo 30
Des Moines 29
Rome 28
Nanchang 26
Munich 24
The Dalles 22
Council Bluffs 21
Hebei 21
Pescara 21
Saint Petersburg 21
Ottawa 20
Columbus 19
Bari 18
São Paulo 18
Shenyang 17
Brooklyn 15
Kochi 15
Bremen 14
Messina 14
Brno 12
Misterbianco 12
New York 12
Changsha 11
Helsinki 11
Quintano 11
Ho Chi Minh City 10
Palermo 10
Seattle 10
Turku 10
Amantea 9
Dearborn 9
Dong Ket 9
San Francisco 9
Aci Castello 8
Hong Kong 8
Iserlohn 8
Jiaxing 8
Milan 8
Naples 8
Norwalk 8
Woodbridge 8
Padova 7
Crema 6
Jinan 6
Mexico City 6
Moscow 6
Parma 6
Pune 6
Rio de Janeiro 6
Stockholm 6
Tianjin 6
Tokyo 6
Agrigento 5
Ann Arbor 5
Boston 5
Brussels 5
Enna 5
Hanoi 5
Montreal 5
Warsaw 5
Abuja 4
Atlanta 4
Baku 4
Belo Horizonte 4
Campinas 4
Capo d'Orlando 4
Carrara 4
Caxias do Sul 4
Den Haag 4
Fairfield 4
Falls Church 4
Frankfurt am Main 4
Genoa 4
Jakarta 4
Lappeenranta 4
Totale 5.523
Salva come PNG Salva come JPEG
Nome #
Time to Separate Persistent from Recurrent Differentiated Thyroid Cancer: Different Conditions with Different Outcomes 257
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 162
Chemioterapia con fluorouracile (FU) in infusione continua e vinorelbina (VNB) nel carcinoma differenziato della tiroide (CDT) in fase avanzata 133
Absorbed Dose Evaluation in Radioiodine Therapy with Different Approaches 128
Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis 124
Effect of low-dose tungsten on human thyroid stem/precursor cells and their progeny 116
Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer 114
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 107
A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma 105
Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases 100
Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution 98
Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors 98
Soggetti trattati con chemio e/o radioterapia in età pediatrica per neoplasia: patologia tiroidea (morfo-funzione) 94
[Differentiated carcinoma of the thyroid in the young. Clinical and histopathologic aspects] 94
Editorial: Clinical and molecular epidemiology of thyroid cancer of follicular origin 92
Persistenza vs Recidiva di malattia nel Carcinoma Differenziato della Tiroide 91
Caratteristiche istologiche alla diagnosi e decorso clinico in pazienti tiroidectomizzati per carcinoma papillare variante sclerosante diffusa: studio di metanalisi. 89
Worldwide increasing incidence of thyroid cancer:update on epidemiology and risk factors 88
BRAF(V600E) mutation and the biology of papillary thyroid cancer 88
Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods 88
Caratteristiche cliniche e istologiche di una serie di 23 pazienti affetti da carcinoma tiroideo della cisti del dotto tireoglosso 87
Orbital metastasis from thyroid cancer: a case report and review of the literature 86
Caratteristiche istologiche e cliniche della variante sclerosante diffusa del carcinoma papillifero tiroideo 85
Papillary Thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries 84
Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 84
Increased thyroid cancer incidence in volcanic areas: A role of increased heavy metals in the environment? 84
BRAF T1799A Mutation in Thyroid Cancer Predicts Progressive disease 83
Differentiated thyroid cancer in children and adolescents 83
Early occurrence of a thyroid carcinoma in a patient who developed Graves’ disease after treatment for Hodgkin’s disease 83
Risk of benign and malignant thyroid disorders in subjects treated for paediatric/adolescent neoplasia: Role of morphological and functional screening 82
Outcome of differentiated thyroid cancer in Graves' patients 81
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas 81
EP-1773 Radioiodine therapy: a dosimetric study in a patient with DTC after rhTSH stimulation 80
Heavy Metals in the Environment and Thyroid Cancer 79
L’ipertiroidismo è un fattore di rischio di trombosi venosa e arteriosa: descrizione di un caso clinico 79
Increased mortality in patients with differentiated thyroid cancer associated with graves' disease 79
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome 79
Papillary thyroid cancer incidence in the volcanic area of Sicily 78
Several site-specific cancers are increased in the volcanic area in Sicily 77
Long-term outcome of patients with insular carcinoma of the thyroid 77
Impact of post-operative radioiodine remnant abalation in differentiated thyroid cancer according to risk categories. 76
Lymph node location is a risk factor for papillary thyroid cancer-related death 75
Risk-stratified evaluation of over 16000 thyroid microcarcinomas: at presentation more than one third have two or more risk factors for recurrence. 72
Ruolo prognostico dello status linfonodale alla diagnosi sull’evoluzione clinica di 4292 pazienti tiroidectomizzati per carcinoma differenziato della tiroide (CDT). 70
The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels 69
Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment 68
Mortality of differentiated thyroid cancer in Graves’s patients. 68
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 68
Is multifocality a risk factor in low-risk papillary thyroid cancer? 67
Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension. 67
Response to Letter to the Editor: "Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes" 67
Thyroid cancer in thyroglossal dust cyst requires a specific approach due to its unpredictable extension. 66
Evidenza RMN di metastasi orbitaria da carcinoma papillifero tiroideo avanzato: rara osservazione successiva a remota chemio- e radioterapia per Linfoma non Hodgkin 64
Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer 63
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes. 61
Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM 60
The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome. 60
TSH ricombinante umano nei pazienti con carcinoma tiroideo differenziato: utilità del follow-up a breve e a lungo termine 60
Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol 59
Metastatic malignant struma ovarii with coexistence of Hashimoto’s thyroiditis 59
Chemotherapy with continous infusion of fluorouracil (FU) and vinorelbine (VNB) in advanced differentiated thyroid cancer (DTC) 59
Ruolo della 18FDG PET nel follow-up del carcinoma differenziato della tiroide (CDT) in presenza di valori di Tireoglobulina (Tg) indosabili, AAT elevati e TBS post-131-I negativo: esperienza clinica in una paziente 58
Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients 58
Utilità del dosaggio ultrasensibile della tireoglobulina per il follow-up dei pazienti con carcinoma tiroideo differenziato classificati per livello di rischio di recidiva. 58
Occurrence of distant metastates as the first sign of disease is a strong prognostic factor of poor outcome in patients with differentiated thyroid cancer 58
Valore predittivo del dosaggio della tireoglobulina sierica alla prima valutazione post-tiroidectomia nei pazienti con carcinoma papillifero della tiroide di piccole dimensioni 57
Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin. 56
Thyroglobulin measurements after rhTSH stimulation in the follow-up of patients with differentiated thyroid cancer 56
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 55
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 55
Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato 55
The new AJCC/TNM Staging System (VIII ed.) in papillary thyroid cancer: clinical and molecular impact on overall and recurrence free survival 55
Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer 54
Proposta di modifica della stadiazione TNM dei pazienti con carcinoma tiroideo a bass rischio (stadio I). 54
Familial non-medullary thyroid cancer represents an independent risk factor for increased cancer aggressiveness: A retrospective analysis of 74 families 53
Cardiac arrest after intravenous calcium administration for calcitonin stimulation test 53
Prognostic factors for adrenocortical carcinoma outcomes 53
Giant parathyroid adenoma: a rare cause of primary hyperparathyroidism mimicking a carcinoma 52
Update on thyroid cancer treatment 52
Prognostic significance of serum Tg in differentiated thyroid cancer (DTC) patients before 131-I ablation and its correlation with neck 131-I uptake. 52
Recurrent parathyromatosis in a patient with concomitant MEN1 and CASR gene alterations: Clinical management of a case report and literature review 51
Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study 51
Usefulness of rhTSH in the management of differentiated thyroid cancer 51
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: A 2015 position statement of the Italian Society of Endocrinology 50
Antioxidant Defense Capacity Is Reduced in Thyroid Stem/Precursor Cells Compared to Differentiated Thyrocytes 49
Thyroid Tumor Registry of Sicily: Molecular Epidemiology 49
Predictive factors of persistent disease in a large cohort of pediatric patients with differentiated thyroid carcinoma 48
Descriptive epidemiology of human thyroid cancer: Experience from a regional registry and the "volcanic factor" 47
Pancreatic Neuroendocrine Tumors: Experience from a Single Institute 45
Long-term outcome in patients with differentiated thyroid cancer and skull metastases 45
Response: Re: Papillary thyroid cancer incidence in the volcanic area of sicily 44
False positive 131I total body scan due to bilateral polycystic renal disease 44
Usefulness of recombinant human TSH (rhTSH) in the radiometabolic treatment of selected thyroid cancer patients 44
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer 43
The influence of the environment on the development of thyroid tumors: A new appraisal 42
Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging 42
Gestione del carcinoma tiroideo in età pediatrica [Management of thyroid carcinoma in the paediatric age] 42
European consensus for the treatment of patients with differentiated thyroid carcinoma of the follicular epithelium [Consenso europeo para el tratamiento de los pacientes con carcinoma tiroideo diferenciado del epitelio folicular] 42
Type I gastric carcinoid in a young woman with polyglandular autoimmune syndrome type III. 2013 40
Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine 39
Totale 7.227
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.711
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021364 0 0 0 7 106 13 41 8 104 7 46 32
2021/2022484 60 70 3 12 71 2 73 17 46 0 15 115
2022/20231.056 71 67 16 135 98 153 19 193 235 8 32 29
2023/2024671 30 94 20 33 23 166 0 76 9 15 74 131
2024/20252.341 26 372 162 144 475 296 69 69 120 183 201 224
2025/20261.797 349 490 890 68 0 0 0 0 0 0 0 0
Totale 7.518